Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2369723 | 0.84 | SMN1; SMN2 (0.51) | ALDH1A1SMN1; SMN2LMNALTA4HKMT2A | |
| SCHEMBL2577502 | 0.82 | LTA4H (0.50) | ALDH1A1SMN1; SMN2LMNAALOX5LTA4H | |
| SCHEMBL2579095 | 0.82 | ALOX5 (0.54) | ALDH1A1SMN1; SMN2LMNAALOX5LTA4H | |
| SCHEMBL2580758 | 0.81 | ALOX5 (0.49) | ALDH1A1SMN1; SMN2LMNAALOX5LTA4H | |
| SCHEMBL560292 | 0.79 | ALDH1A1 (0.48) | ALDH1A1LMNAALOX5KMT2AMEN1 | |
| SCHEMBL30064859 | 0.79 | ALDH1A1 (0.48) | ALDH1A1LMNAALOX5KMT2AMEN1 | |
| SCHEMBL4292188 | 0.78 | ALDH1A1 (0.49) | ALDH1A1SMN1; SMN2LMNAALOX5LTA4H | |
| SCHEMBL10383678 | 0.77 | ALDH1A1 (0.48) | ALDH1A1SMN1; SMN2LMNALTA4HNPSR1 | |
| SCHEMBL28849552 | 0.76 | ALOX5 (0.48) | ALOX5LTA4HVKORC1KMT2AMEN1 | |
| SCHEMBL29256757 | 0.76 | CALM1 (0.55) | ALDH1A1SMN1; SMN2ALOX5LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101472937-A | Benzylphenylglucopyranoside Derivatives | DAIICHI SANKYO CO LTD (JP) | 2009-07-01 | — | — | CN | disclosed |
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2048150-A1 | BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137499-A1 | BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | ALDH1A1 896/4885SMN1; SMN2 4337/4885LMNA 3975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.